Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
Justus Gerhard GarwegJana ŠtefanickovaCarel HoyngTobias NiesenThomas SchmelterSergio LealSobha Sivaprasadnull nullPublished in: Advances in therapy (2022)
ClinicalTrials.gov identifier: NCT02818998.